A Phase 2 Clinical Study of MIL62 in Systemic Lupus Erythematosus
Clinical trial NCT05796206 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05796206
- Sponsor
- Beijing Mabworks Biotech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-26
- Primary completion
- 2026-02-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.